文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

短链脂肪酸及其受体:新的代谢靶点。

Short chain fatty acids and their receptors: new metabolic targets.

机构信息

Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611-3008, USA.

出版信息

Transl Res. 2013 Mar;161(3):131-40. doi: 10.1016/j.trsl.2012.10.007. Epub 2012 Nov 9.


DOI:10.1016/j.trsl.2012.10.007
PMID:23146568
Abstract

Fatty acids are carboxylic acids with aliphatic tails of different lengths, where short chain fatty acids (SCFAs) typically refer to carboxylic acids with aliphatic tails less than 6 carbons. In humans, SCFAs are derived in large part from fermentation of carbohydrates and proteins in the colon. By this process, the host is able to salvage energy from foods that cannot be processed normally in the upper parts of the gastrointestinal tract. In humans, SCFAs are a minor nutrient source, especially for people on Western diets. Intriguingly, recent studies, as highlighted here, have described multiple beneficial roles of SCFAs in the regulation of metabolism. Further interest in SCFAs has emerged due to the association of gut flora composition with obesity and other metabolic states. The recent identification of receptors specifically activated by SCFAs has further increased interest in this area. These receptors, free fatty acid receptor-2 and -3 (FFAR2 and FFAR3), are expressed not only in the gut epithelium where SCFAs are produced, but also at multiple other sites considered to be metabolically important, such as adipose tissue and pancreatic islets. Because of these relatively recent findings, studies examining the role of these receptors, FFAR2 and FFAR3, and their ligands, SCFAs, in metabolism are emerging. This review provides a critical analysis of SCFAs, their recently identified receptors, and their connection to metabolism.

摘要

脂肪酸是具有不同长度脂肪链的羧酸,其中短链脂肪酸(SCFAs)通常是指具有 6 个碳原子以下脂肪链的羧酸。在人类中,SCFAs 主要来源于结肠中碳水化合物和蛋白质的发酵。通过这个过程,宿主能够从不能在上消化道正常处理的食物中获取能量。在人类中,SCFAs 是一种次要的营养来源,尤其是对于西方饮食的人来说。有趣的是,正如这里所强调的,最近的研究描述了 SCFAs 在代谢调节中的多种有益作用。由于肠道菌群组成与肥胖和其他代谢状态有关,人们对 SCFAs 的兴趣进一步增加。最近鉴定出的专门被 SCFAs 激活的受体进一步增加了人们对这一领域的兴趣。这些受体,即游离脂肪酸受体-2 和 -3(FFAR2 和 FFAR3),不仅在产生 SCFAs 的肠道上皮细胞中表达,而且在其他被认为在代谢上很重要的多个部位表达,如脂肪组织和胰岛。由于这些相对较新的发现,研究这些受体(FFAR2 和 FFAR3)及其配体,SCFAs,在代谢中的作用的研究正在出现。这篇综述对 SCFAs、它们最近被鉴定出的受体以及它们与代谢的联系进行了批判性分析。

相似文献

[1]
Short chain fatty acids and their receptors: new metabolic targets.

Transl Res. 2012-11-9

[2]
The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.

Am J Physiol Gastrointest Liver Physiol. 2018-3-1

[3]
Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3.

Sci Rep. 2019-11-12

[4]
FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.

FASEB J. 2017-9-7

[5]
Short-chain fatty acids: possible regulators of insulin secretion.

Mol Cell Biochem. 2023-3

[6]
[Host energy regulation via SCFAs receptors, as dietary nutrition sensors, by gut microbiota].

Yakugaku Zasshi. 2014

[7]
Free Fatty Acid Receptors in Health and Disease.

Physiol Rev. 2019-9-5

[8]
Short-Chain Fatty Acid Receptors and Cardiovascular Function.

Int J Mol Sci. 2022-3-18

[9]
The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis.

Am J Physiol Endocrinol Metab. 2015-11-15

[10]
Gut feelings in the islets: The role of the gut microbiome and the FFA2 and FFA3 receptors for short chain fatty acids on β-cell function and metabolic regulation.

Br J Pharmacol. 2023-12

引用本文的文献

[1]
Investigation into the Anti-hyperglycemic Traits and Bioactive Constituents of Postbiotics Derived from Lacticaseibacillus paracasei NCUH012072.

Probiotics Antimicrob Proteins. 2025-8-29

[2]
The role of gut microbiota in insulin resistance: recent progress.

Front Microbiol. 2025-7-25

[3]
Combining a diet rich in fermentable carbohydrates with metformin improves glycaemic control and reshapes the gut microbiota in people with prediabetes.

Nat Metab. 2025-7-31

[4]
Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions.

Front Med (Lausanne). 2025-7-15

[5]
Gut microbiota-metabolome crosstalk in allergic diseases: mechanistic insights and translational opportunities.

Front Allergy. 2025-7-15

[6]
Rewiring the Brain Through the Gut: Insights into Microbiota-Nervous System Interactions.

Curr Issues Mol Biol. 2025-6-26

[7]
Butyrate Produced by Gut Microbiota Regulates Atherosclerosis: A Narrative Review of the Latest Findings.

Int J Mol Sci. 2025-7-14

[8]
Symptom-specific gut microbial and metabolic profiles in ADHD reveal SCFA deficiency as a Key pathogenic mechanism.

Gut Microbes. 2025-12

[9]
Gut microbiota-derived butyrate prevents aortic dissection via GPR41.

Acta Pharmacol Sin. 2025-6-23

[10]
The Influences of Oral Probiotics on the Immunometabolic Response During Pregnancy and Lactation: A Systematic Review.

Nutrients. 2025-4-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索